How Is The Flow Cytometry In Oncology And Immunology Market Expected To Grow At 10.4% CAGR Over 2025–2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Flow Cytometry In Oncology And Immunology Market Be Worth By 2029?
The market size for flow cytometry in oncology and immunology has seen a swift expansion in recent times. It is projected to elevate from a value of $2.11 billion in 2024 to be worth an estimated $2.32 billion in 2025, displaying a compound annual growth rate (CAGR) of 10.1%. The historical growth pattern can be linked to progressions in cancer research, developments in immunology research, improved diagnostic applications, the increasing prevalence of autoimmune diseases, drug developments, and clinical trials.
The oncology and immunology sector of flow cytometry is anticipated to undergo significant expansion in the coming years, reaching a market size of $3.45 billion in 2029, with a compound annual growth rate (CAGR) of 10.4%. Factors contributing to this predicted growth include amalgamation with genomics and proteomics, increased utilization of single-cell analysis, a growing role in infectious disease applications, a rise in cancer rates, and the emergence of point-of-care flow cytometry. Notable trends projected for this period encompass immunophenotyping applied to immunotherapy, the miniaturization of flow cytometry systems, multiparametric analysis, a shift towards spectral flow cytometry, and joint research initiatives.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp
What External And Internal Drivers Are Influencing The Flow Cytometry In Oncology And Immunology Market?
The surge in cancer cases is anticipated to drive the expansion of flow cytometry in the oncology and immunology sector in the future. Described as a collection of disorders marked by the unchecked proliferation and spread of atypical cells within the body, cancer is a key focus of flow cytometry, a technique heavily utilized in both cancer and immune cell research. To illustrate, Macmillan Cancer Support, a healthcare charity based in the UK, reported in October 2022 that the number of cancer patients was 3 million in 2020. The figure is predicted to reach 3.5 million by 2025, surge to 4 million by 2030, and jump to 5.3 million by 2040. This escalating incidence of cancer is bolstering the growth of the flow cytometry market in the oncology and immunology domains.
What Segmentation Insights Are Provided In The Flow Cytometry In Oncology And Immunology Market Research?
The flow cytometry in oncology and immunologymarket covered in this report is segmented –
1) By Type: Immunology; Oncology
2) By Technology: Cell-Based Flow Cytometry; Bead-Based Flow Cytometry
3) By Application: Translational Research; Clinical Research
4) By End User: Hospitals; Diagnostic Laboratories; Reference Laboratories; Pharmaceutical And Biotechnology Companies; Academic Research Institutes; Contract Research Organizations; Other End Users
Subsegments:
1) By Immunology: Immune Cell Profiling; Cytokine Detection; T-Cell And B-Cell Analysis; Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis; Tumor Microenvironment Studies; Minimal Residual Disease Detection; Biomarker Discovery And Validation
Which Trends Are Likely To Redefine Growth Paths In The Flow Cytometry In Oncology And Immunology Market?
As a prevailing trend, technological advancements continue to shape the flow cytometry scene within the oncology and immunology markets. Key players in these markets are adopting cutting-edge technologies to secure their standing. In September 2022, an American medical technology firm, Becton Dickinson, launched BD Research Cloud, a specialized solution for flow cytometry within these specific markets. The BD Cloud, an advanced cloud-based software system, streamlines the flow cytometry procedures for researchers across diverse fields like immunology, virology, infectious disease, and even oncology surveillance. It paves the way for superior quality studies with quick insights. To augment the competencies of flow cytometry, BD incorporates innovative technologies such as BD Horizon RealYellow and RealBlue Reagents alongside their recently launched BD FACSDiscover S8 Cell Sorter coupled with BD CellView Image Technology. This allows researchers to push the boundaries of their pioneering research. Built on a reliable, industry-grade cloud framework, the BD Research Cloud is specially designed for BD equipment and chemicals.
Who Are The Leading Companies Driving The Flow Cytometry In Oncology And Immunology Market?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Flow Cytometry In Oncology And Immunology Market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12469&type=smp
Browse Through More Reports Similar to the Global Flow Cytometry In Oncology And Immunology Market 2025, By The Business Research Company
Flow Cytometry Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report
Immuno Oncology Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
Interventional Oncology Devices Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
